1. Home
  2. Browse Decisions
  3. F.Supp.3d
  4. 645 F.Supp.3d
  5. 645 F.Supp.3d 335 (2022)
 

FERRING PHARMACEUTICALS INC. v. FRESENIUS KABI USA

C.A. No. 20-431 (MN).

645 F.Supp.3d 335 (2022)

FERRING PHARMACEUTICALS INC., Ferring International Center, S.A., Ferring B.V., and Polypeptide Laboratories A/S, Plaintiffs, v. FRESENIUS KABI USA, LLC, Defendant.

United States District Court, D. Delaware.

Signed December 12, 2022.

Attorney(s) appearing for the Case

Mary W. Bourke, Dana K. Severance, Daniel M. Attaway, John B. Bourke, Womble Bond Dickinson (US) LLP, Wilmington, DE; Joshua P. Davis, Womble Bond Dickinson (US) LLP, Houston, TX — Attorneys for Plaintiffs.

Brian E. Farnan, Michael J. Farnan, Farnan LLP, Wilmington, DE; Imron T. Aly, Joel M. Wallace, Thomas R. Rammer, Schiff Hardin, LLP, Chicago, IL; John K. Hsu, Schiff Hardin LLP, Washington, DC — Attorneys for Defendant.

MEMORANDUM OPINION

Plaintiffs Ferring Pharmaceuticals Inc., Ferring International Center, S.A., Ferring B.V. and Polypeptide Laboratories A/S (collectively, "Plaintiffs" or "Ferring") brought this Hatch-Waxman action against Defendant Fresenius Kabi USA, LLC ("Defendant" or...

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases